Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 63

Sort by

Sort Order Select

Journal Articles

Peri-Procedural Management and Outcomes of Patients with Hemophilia on Emicizumab Prophylaxis

Isabella McCary, BS, Christine Guelcher, PPCNP-BC, Jan Kuhn, BA, BSN, MSN, Regina Butler, RN-BC, Michael F. Guerrera, MD, Gita Massey, Leslie J. Raffini, MD

Blood (2019) 134 (Supplement_1): 2396.

https://doi.org/10.1182/blood-2019-126944

Published: 2019

Journal Articles

Successful Treatment of Mucosal Bleeding with Tranexamic Acid in Pediatric Patients with Hemostatic Disorders

Hisaya Nakadate, MD PhD, Akira Ishiguro, MD PhD, Atsushi Sakamoto, MD

Blood (2019) 134 (Supplement_1): 4902.

https://doi.org/10.1182/blood-2019-129360

Published: 2019

Journal Articles

Long Acting Zoledronic Acid Treatment for Vertebral Fracture Prevention in Multipl Myeloma Patients with Osteoporosis

Murat Cinarsoy, Ahmet Kursad Gunes, Hilmi Erdem Gozden

Blood (2018) 132 (Supplement 1): 1954.

https://doi.org/10.1182/blood-2018-99-111133

Published: 2018

Journal Articles

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Mark T. Reding, MD, Jatin Rana, MD, Michael U. Callaghan, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD

Blood (2018) 132 (Supplement 1): 635.

https://doi.org/10.1182/blood-2018-99-115089

Published: 2018

Journal Articles

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Rebecca Kruse-Jarres, Michael U. Callaghan, Stacy E. Croteau, MD, Victor Jimenez-Yuste, Liane Khoo, Ri Liesner, Tadashi Matsushita, Michael Recht, Guy Young, Tiffany Chang, Christophe Dhalluin, Yunming Mu, Jin Xu, Jenny Devenport, Richard H. Ko, Paul Solari, Johannes Oldenburg

Blood (2017) 130 (Supplement 1): 89.

https://doi.org/10.1182/blood.V130.Suppl_1.89.89

Published: 2017

Journal Articles

Platelet Response to Lusutrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Non-Emergency Invasive Procedures: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Nezam Afdhal, MD, Ajay Duggal, MD, Toshimitsu Ochiai, Tomoko Motomiya, Takeshi Kano, MSc, Tsutae Nagata, MD, Markus Peck-Radosavljevic, MD

Blood (2017) 130 (Supplement 1): 291.

https://doi.org/10.1182/blood.V130.Suppl_1.291.291

Published: 2017

Journal Articles

Spectrum of Hematological Disorders in Young Navy Recruits

Dhauna Karam, MD, Bharat L. Agrawal, MD

Blood (2017) 130 (Supplement 1): 4638.

https://doi.org/10.1182/blood.V130.Suppl_1.4638.4638

Published: 2017

Journal Articles

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Mahsen AlSaleh, MD, Tarek Owaidah, MD, Hazzaa Alzahrani, MD, Tahani Bin Ali, MD, Huda ElFaraidi, MD, Mahmoud Abu Riash, RN, Zikra Alkhayal, MD, AbdulKareem Al Momen, MD, Viqaruddin Mohammed, MSc, CCRP, Azzah AlZahrani, MD

Blood (2017) 130 (Supplement 1): 5587.

https://doi.org/10.1182/blood.V130.Suppl_1.5587.5587

Published: 2017

Journal Articles

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Jessica Garcia, MD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, Paula D. James, MD, Pippa Simpson, PhD, Liyun Zhang, MS, Thomas C. Abshire, MD, Zimmerman Program Investigators

Blood (2017) 130 (Supplement 1): 1075.

https://doi.org/10.1182/blood.V130.Suppl_1.1075.1075

Published: 2017

Journal Articles

Perioperative Management of Von Willebrand Disease: An Institutional Experience

Craig D. Seaman, Margaret V. Ragni, MD MPH

Blood (2017) 130 (Supplement 1): 1081.

https://doi.org/10.1182/blood.V130.Suppl_1.1081.1081

Published: 2017

Journal Articles

Are Bleeding Scores Predicting Severity and Outcome in Hemophilia and Rare Bleeding Disorders?

Mahdi Shahriari, MD, Mehran Karimi, MD

Blood (2016) 128 (22): 4801.

https://doi.org/10.1182/blood.V128.22.4801.4801

Published: 2016

Journal Articles

Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Kristen M Scheitler, Post-Sophomore Fellow, Emily A Coberly, MD, A. Mosharraf Hossain, MD, Richard D Hammer, MD

Blood (2016) 128 (22): 4989.

https://doi.org/10.1182/blood.V128.22.4989.4989

Published: 2016

Journal Articles

Phenotype Analysis and Clinical Management in a Large Family with a Novel Truncating Mutation in RASGRP2 , the Caldag-GEFI Encoding Gene

Amrita Desai, MD MPH, Wenche Jy, PhD, Wolfgang Bergmeier, PhD, Mathias Canault, PhD, Marie-Christine Alessi, MD PhD, Paquita Nurden, MD PhD, Yeon-Soong Ahn, MD, Alan T. Nurden, PhD

Blood (2016) 128 (22): 3713.

https://doi.org/10.1182/blood.V128.22.3713.3713

Published: 2016

Journal Articles

Ibrutinib in Patients (Pts) with Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL) with Relapsed Disease Post Allogeneic Stem Cell Transplantation (alloSCT)

Issa F. Khouri, Elias Jabbour, Rima M Saliba, PhD, Celina Ledesma, Jan A Burger, MD PhD, Susan O'Brien, MD, Alison M Gulbis

Blood (2015) 126 (23): 4345.

https://doi.org/10.1182/blood.V126.23.4345.4345

Published: 2015

Journal Articles

Patients with Mild Hemophilia a with Discrepant FVIII Assays: Thrombin Generation and Bleeding Phenotype

Maria Elisa Mancuso, MD PhD, Maria Rosaria Fasulo, MD, Antonino Cannavò, MD, Flora Peyvandi, MD PhD, Elena Santagostino, MD PhD

Blood (2014) 124 (21): 2844.

https://doi.org/10.1182/blood.V124.21.2844.2844

Published: 2014

Journal Articles

Two Cases of Dysfibrinogenemia in Childhood

Roman Kotlin, Ondrej Pastva, Jaromir Novak, Jiri Suttnar, Peter Salaj, Jaroslav Cermak, Jan E Dyr

Blood (2014) 124 (21): 5066.

https://doi.org/10.1182/blood.V124.21.5066.5066

Published: 2014

Journal Articles

Contact Activation Inhibition and Platelet Rich Plasma Are Required in Order to Differentiate Bleeders from Non-Bleeders in FXI Deficiency Using the Thrombin Generation Assay

Gillian N Pike, MBChB, MRCP, Anthony M Cumming, PhD FRCPath, Charles R.M Hay, MD FRCP, FRCPath, Jecko Thachil, MD MRCP, FRCPath, John Burthem, PhD FRCP, FRCPath, Paula H. B Bolton-Maggs, BMBCh, DM, FRCP, FRCPath

Blood (2014) 124 (21): 696.

https://doi.org/10.1182/blood.V124.21.696.696

Published: 2014

Journal Articles

Romiplostim in Management of the Thrombocytopenic Surgical Patient

Ariela L. Marshall, MD, Katayoon Goodarzi, MD, David J. Kuter, MD DPhil

Blood (2014) 124 (21): 1459.

https://doi.org/10.1182/blood.V124.21.1459.1459

Published: 2014

Journal Articles

Impact of Age and Gender on Bleeding Score in Type 1 VWD Using the ISTH-BAT

Pamela A Christopherson, Veronica H Flood, MD, Kenneth D. Friedman, MD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Robert R Montgomery, MD, Thomas C. Abshire, MD, the Zimmerman Program Investigators

Blood (2014) 124 (21): 1510.

https://doi.org/10.1182/blood.V124.21.1510.1510

Published: 2014

Journal Articles

Analysis of Bleeding Phenotype of Severe Hemophilia a Carriers and Comparation with a Working Population Group. Impact on Quality of Life

María Eva Mingot-Castellano, María Jose Ariza-Corbo, Álvaro Amo Vázquez de la Torre, María Inmaculada Alonso-Calderón, Pedro Valdivielso, Ana Isabel Heiniger-Mazo, Miguel Angel Sánchez-Chaparro

Blood (2014) 124 (21): 5053.

https://doi.org/10.1182/blood.V124.21.5053.5053

Published: 2014

NARROW

Peri-Procedural Management and Outcomes of Patients with Hemophilia on Emicizumab Prophylaxis

Successful Treatment of Mucosal Bleeding with Tranexamic Acid in Pediatric Patients with Hemostatic Disorders

Long Acting Zoledronic Acid Treatment for Vertebral Fracture Prevention in Multipl Myeloma Patients with Osteoporosis

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Platelet Response to Lusutrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Non-Emergency Invasive Procedures: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Spectrum of Hematological Disorders in Young Navy Recruits

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Perioperative Management of Von Willebrand Disease: An Institutional Experience

Are Bleeding Scores Predicting Severity and Outcome in Hemophilia and Rare Bleeding Disorders?

Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Phenotype Analysis and Clinical Management in a Large Family with a Novel Truncating Mutation in RASGRP2 , the Caldag-GEFI Encoding Gene

Ibrutinib in Patients (Pts) with Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL) with Relapsed Disease Post Allogeneic Stem Cell Transplantation (alloSCT)

Patients with Mild Hemophilia a with Discrepant FVIII Assays: Thrombin Generation and Bleeding Phenotype

Two Cases of Dysfibrinogenemia in Childhood

Contact Activation Inhibition and Platelet Rich Plasma Are Required in Order to Differentiate Bleeders from Non-Bleeders in FXI Deficiency Using the Thrombin Generation Assay

Romiplostim in Management of the Thrombocytopenic Surgical Patient

Impact of Age and Gender on Bleeding Score in Type 1 VWD Using the ISTH-BAT

Analysis of Bleeding Phenotype of Severe Hemophilia a Carriers and Comparation with a Working Population Group. Impact on Quality of Life

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only